MiNA Therapeutics

RNA Activation – MiNA Therapeutics | RNA Activation

London, United Kingdom · Founded 2008 · $175.0M raised

Headquarters
London
Employees
11–50
Founded
2008
Business Model
B2B
Website
minatx.com
Total Funding
$175.0M
Last Round
$130.0M Series CJan 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

MiNA Therapeutics is the global leader in small activating RNA (RNAa) therapeutics, harnessing innate mechanisms of gene activation to restore or boost normal gene function. The company advances a proprietary pipeline focused on genetic medicine while collaborating with leading pharmaceutical companies including Eli Lilly to apply its RNAa platform across a broad range of therapeutic areas.

Summary

MiNA Therapeutics is a Biotech company based in London, United Kingdom, founded in 2008. It has raised $175.0M in total across 3 rounds, most recently a $130.0M Series C round in Jan 2023. Investors include Eli Lilly and aMoon.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries C2023 (est.)
$130.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MiNA Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mina-therapeutics"><img src="https://indexed.vc/api/badge/company/mina-therapeutics" alt="MiNA Therapeutics on Indexed.vc" width="260" height="76" /></a>